TDOC
Teladoc Health, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Jun 2 to Jun 3 ▼ 2 days of insider sells: $428.3K by 6 insiders, avg $7.59
- Jun 29 to Jul 6 ▼ 4 days of insider sells: $73.4K by 2 insiders, avg $9.01
- Sep 2 to Sep 3 ▼ 2 days of insider sells: $348.5K by 6 insiders, avg $6.34
- Sep 11 ▼ 1 insider sell $108.7K at $6.10
- Oct 2 ▼ 1 insider sell $3.7K at $5.65
- Oct 28 ▼ Teladoc Health reported Q3 2026 revenue of $605.1M, down 3% YoY but…
- Oct 28 ▼ Teladoc Health reported Q3 2026 revenue of $605.1M, down 3% YoY and…
- Oct 28 ▲ Earnings: TDOC Q3 2026 Earnings: EPS $-0.15 (+29.3% vs est)
- Nov 3 Activist stake: Teladoc Health Announces Employee Inducement Awards under…
- Nov 6 ▼ 1 insider sell $270.8K at $9.20
Signal stack
Where each data set points today.
- InsidersBEARISH
6 insiders sold $1.2M.
- InstitutionsBULLISH
Q3 2026: 25 added (0 new), 16 trimmed or exited.
- AnalystsMIXED
10 of 29 rate it Buy or better. Median target $8.75 (+1%).
- Short sellersSTEADY
Short interest +0.4% to 32.19M shares. 5.7 days to cover, ≈17.7% of shares.
- TrendUPTREND
28% above its 50-day average.
- SocialQUIET
No Reddit mentions this week. Last mention Nov 7.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| AMERICAN CENTURY COMPANIES INC | ADD | $55.2M |
| MORGAN STANLEY | ADD | $11.4M |
| Walleye Capital LLC | DOUBLED | $6.1M |
| BNP PARIBAS FINANCIAL MARKETS | TRIM | $3.8M |
| BARCLAYS PLC | DOUBLED | $2.7M |
| MACKENZIE FINANCIAL CORP | DOUBLED | $2.5M |
| Russell Investments Group, Ltd. | ADD | $2.0M |
| SEI INVESTMENTS CO | DOUBLED | $1.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
29 analystsPrice is inside the target range. Median implies +1%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 9, 2026 | TD Cowen MAINTAIN | Hold |
| Nov 5, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Nov 4, 2026 | Barclays MAINTAIN | Equal-Weight |
| Nov 2, 2026 | UBS MAINTAIN | Neutral |
| Nov 2, 2026 | Oppenheimer MAINTAIN | Outperform |
| Oct 30, 2026 | JP Morgan MAINTAIN | Neutral |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Nueno Carlos President, International Nov 6, 2026 | SELL | $270.8K |
Catapano Joseph Ronald Chief Accounting Officer Oct 2, 2026 | SELL | $3.7K |
Catapano Joseph Ronald Chief Accounting Officer Oct 1, 2026 | EXERCISE | 2,083 sh |
DIVITA CHARLES III CHIEF EXECUTIVE OFFICER Sep 11, 2026 | SELL | $108.7K |
DIVITA CHARLES III CHIEF EXECUTIVE OFFICER Sep 10, 2026 | EXERCISE | 3,642 sh |
DIVITA CHARLES III CHIEF EXECUTIVE OFFICER Sep 10, 2026 | EXERCISE | 39,160 sh |
Rodrigues Fernando M. President of BetterHelp Sep 3, 2026 | SELL | $63.9K |
Bliss Kelly President, U.S. Group Health Sep 2, 2026 | SELL | $46.4K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
23 filings · 1 press release · 0 bullish · 4 bearish · 1 mixed · 18 neutral- NEUTRAL SC 13GNov 16, 2026
American Century Investment Management Inc. filed a Schedule 13G disclosing a 5.2% passive stake in Teladoc Health as of September 30, 2026, representing 9,511,923 shares. This is a routine passive filing by a large asset manager, indicating no intent to influence management.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 144Nov 6, 2026
Carlos Nueno, an officer of Teladoc Health, filed a Form 144 notice of intent to sell 29,432…
The proposed sale is small relative to market cap and appears to be a routine diversification move following vesting of equity compensation. Monitor for actual Form 4 filings to confirm execution…
- NEUTRAL 3, PRESS-RELEASENov 3, 2026
Jonathan Dorfman filed a Form 3 initial beneficial ownership statement as Chief Legal Officer and…
These are routine onboarding filings and inducement grants for new executives and acquisition hires. No material financial impact; monitor for any subsequent insider trading activity or further…
- NEUTRAL PTAB-TRIALNov 3, 2026
The PTAB granted institution of IPR2026-00391, finding Teladoc Health showed a reasonable…
Monitor the final written decision expected within ~12 months. If the patent is tied to a material product or service, a cancellation could reduce royalty or litigation exposure.
All TDOC filing & press-release reports (24)
- SC 13G reportNov 16, 2026
- 144 reportNov 6, 2026
- 3, PRESS-RELEASE reportNov 3, 2026
- PTAB-TRIAL reportNov 3, 2026
- PTAB-TRIAL reportOct 28, 2026
- PRESS-RELEASE reportOct 28, 2026
- 8-K reportOct 28, 2026
- SC 13G reportOct 8, 2026
- 8-K reportSep 25, 2026
- 144 reportSep 11, 2026
- CLUSTER reportSep 3, 2026
- 144 reportSep 2, 2026
- 144 reportJun 29, 2026
- 144 reportJun 11, 2026
- INST-CLUSTER reportJun 11, 2026
- 144 reportJun 2, 2026
- 144 reportJun 2, 2026
- PRESS-RELEASE reportApr 15, 2026
- DEFA14A reportApr 7, 2026
- 3 reportApr 1, 2026
- PRESS-RELEASE reportMar 30, 2026
- CLUSTER reportMar 2, 2026
- CLUSTER reportMar 2, 2026
- 8-K reportFeb 25, 2026